BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15568210)

  • 1. Semi-parametric modelling for costs of health care technologies.
    Conigliani C; Tancredi A
    Stat Med; 2005 Oct; 24(20):3171-84. PubMed ID: 15568210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric modelling of cost data in medical studies.
    Nixon RM; Thompson SG
    Stat Med; 2004 Apr; 23(8):1311-31. PubMed ID: 15083485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian model averaging approach for cost-effectiveness analyses.
    Conigliani C; Tancredi A
    Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW; Montmartin J
    Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian adjustment for covariate measurement errors: a flexible parametric approach.
    Hossain S; Gustafson P
    Stat Med; 2009 May; 28(11):1580-600. PubMed ID: 19226564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian semi-parametric ROC analysis.
    Erkanli A; Sung M; Costello EJ; Angold A
    Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional form and risk adjustment of hospital costs: Bayesian analysis of a Box-Cox random coefficients model.
    Hollenbeak CS
    Stat Med; 2005 Oct; 24(19):3005-18. PubMed ID: 15977298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large hierarchical Bayesian analysis of multivariate survival data.
    Gustafson P
    Biometrics; 1997 Mar; 53(1):230-42. PubMed ID: 9147593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials.
    Turner RM; Omar RZ; Thompson SG
    Stat Med; 2006 May; 25(9):1443-56. PubMed ID: 16220510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian dynamic modeling of latent trait distributions.
    Dunson DB
    Biostatistics; 2006 Oct; 7(4):551-68. PubMed ID: 16488893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
    Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
    Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proper modeling strategies selection for the assessment of post-infarction costs.
    Gregori D; Desideri A; Bigi R; Petrinco M; Cortigiani L; Zigon G; Pagano E
    Int J Cardiol; 2008 Sep; 129(1):53-8. PubMed ID: 17707925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlated frailty model for analysing risk factors in bilateral corneal graft rejection for Keratoconus: a Bayesian approach.
    Kheiri S; Meshkani MR; Faghihzadeh S
    Stat Med; 2005 Sep; 24(17):2681-93. PubMed ID: 16118807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian model averaging approach with non-informative priors for cost-effectiveness analyses.
    Conigliani C
    Stat Med; 2010 Jul; 29(16):1696-709. PubMed ID: 20572119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
    Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
    J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data.
    Fotouhi AR
    Contemp Clin Trials; 2008 Jul; 29(4):547-54. PubMed ID: 18308644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian methods of analysis for cluster randomized trials with count outcome data.
    Clark AB; Bachmann MO
    Stat Med; 2010 Jan; 29(2):199-209. PubMed ID: 19856321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data cloning: easy maximum likelihood estimation for complex ecological models using Bayesian Markov chain Monte Carlo methods.
    Lele SR; Dennis B; Lutscher F
    Ecol Lett; 2007 Jul; 10(7):551-63. PubMed ID: 17542934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.